CITIGROUP INC

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 831001 NEW YORK, NY

Position in LXEO

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$76,456

-$75,403 QoQ

Shares Held

13,320

-12.9% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

CITIGROUP INC holds $1,427,117,007 across 402 Biotechnology names. LXEO ranks #219 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	682,807	$304,900,636
2	REGN	Regeneron Pharmaceuticals, Inc.	184,691	$142,699,654
3	ALNY	Alnylam Pharmaceuticals, Inc.	263,375	$87,142,884
4	MRNA	Moderna, Inc.	1,480,034	$75,185,727
5	FOLD	AMICUS THERAPEUTICS, INC.	4,226,882	$61,120,713
6	BBIO	BridgeBio Pharma, Inc.	746,483	$55,433,827
7	INCY	Incyte Corp	489,649	$46,085,763
8	ROIV	Roivant Sciences Ltd.	1,536,110	$42,550,246

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$76,456	13,320	-12.9%	Shares	Defined	2026-05-11
2025-12-31	$151,859	15,293	+105.8%	Shares	Defined	2026-02-13
2025-09-30	$49,347	7,432	-49.6%	Shares	Defined	2025-11-10
2025-06-30	$59,286	14,748	-36.8%	Shares	Defined	2025-08-11
2025-03-31	$80,943	23,327	-6.4%	Shares	Defined	2025-05-12
2024-12-31	$163,999	24,924	+7.9%	Shares	Defined	2025-02-12
2024-09-30	$208,869	23,105	+100.1%	Shares	Defined	2024-11-12
2024-06-30	$185,181	11,545	-76.5%	Shares	Defined	2024-08-12
2024-03-31	$771,095	49,177	-46.5%	Shares	Defined	2024-05-10
2023-12-31	$1,233,150	91,889	—	Shares	Defined	2024-02-09
No filing history on record for this holder in this stock.